These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15245864)

  • 21. Activity of 7-methyljuglone in combination with antituberculous drugs against Mycobacterium tuberculosis.
    Bapela NB; Lall N; Fourie PB; Franzblau SG; Van Rensburg CE
    Phytomedicine; 2006 Nov; 13(9-10):630-5. PubMed ID: 16987644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
    Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection.
    Giacometti A; Cirioni O; Kamysz W; Silvestri C; Licci A; Riva A; Łukasiak J; Scalise G
    Peptides; 2005 Nov; 26(11):2111-6. PubMed ID: 16269345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and ex vivo antimycobacterial potential of azole drugs against Mycobacterium tuberculosis H37Rv.
    Ahmad Z; Sharma S; Khuller GK
    FEMS Microbiol Lett; 2005 Oct; 251(1):19-22. PubMed ID: 16143463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice.
    Dutta NK; Mazumdar K; Dastidar SG; Park JH
    Int J Antimicrob Agents; 2007 Oct; 30(4):336-40. PubMed ID: 17644321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotinamide: an oral antimicrobial agent with activity against both Mycobacterium tuberculosis and human immunodeficiency virus.
    Murray MF
    Clin Infect Dis; 2003 Feb; 36(4):453-60. PubMed ID: 12567303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In vitro antituberculous activity of ofloxacin and levofloxacin against multidrug-resistant tuberculosis and clinical outcomes].
    Tada A; Kawata N; Shibayama T; Takahashi S; Hirano A; Kimura G; Takeuchi M; Okada C; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):337-44. PubMed ID: 16715942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
    Evans J; Stead MC; Nicol MP; Segal H
    J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan.
    Hillemann D; Kubica T; Agzamova R; Venera B; Rüsch-Gerdes S; Niemann S
    Int J Tuberc Lung Dis; 2005 Oct; 9(10):1161-7. PubMed ID: 16229229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones.
    Maccari R; Ottanà R; Bottari B; Rotondo E; Vigorita MG
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5731-3. PubMed ID: 15501030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.
    Colangeli R; Helb D; Sridharan S; Sun J; Varma-Basil M; Hazbón MH; Harbacheuski R; Megjugorac NJ; Jacobs WR; Holzenburg A; Sacchettini JC; Alland D
    Mol Microbiol; 2005 Mar; 55(6):1829-40. PubMed ID: 15752203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates.
    Erturan Z; Uzun M
    Int J Antimicrob Agents; 2005 Jul; 26(1):78-80. PubMed ID: 15950439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophages.
    Sood R; Rao M; Singhal S; Rattan A
    Int J Antimicrob Agents; 2005 Jun; 25(6):464-8. PubMed ID: 15885988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of penicillin and penicillin with hydrazines on Mycobacterium tuberculosis in vitro].
    Tybusz R; Dettlaff Z
    Gruzlica; 1966 Jul; 34(7):627-9. PubMed ID: 4959114
    [No Abstract]   [Full Text] [Related]  

  • 37. Antimycobacterial agent based on mRNA encoding human beta-defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis.
    Kisich KO; Heifets L; Higgins M; Diamond G
    Infect Immun; 2001 Apr; 69(4):2692-9. PubMed ID: 11254636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37.
    Abou Alaiwa MH; Reznikov LR; Gansemer ND; Sheets KA; Horswill AR; Stoltz DA; Zabner J; Welsh MJ
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18703-8. PubMed ID: 25512526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of preservative-free artificial tears on the antimicrobial activity of human beta-defensin-2 and cathelicidin LL-37 in vitro.
    Huang LC; Jean D; McDermott AM
    Eye Contact Lens; 2005 Jan; 31(1):34-8. PubMed ID: 15665670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of human beta-defensin 3 alone or combined with other antimicrobial agents against oral bacteria.
    Maisetta G; Batoni G; Esin S; Luperini F; Pardini M; Bottai D; Florio W; Giuca MR; Gabriele M; Campa M
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3349-51. PubMed ID: 14506056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.